Cord blood banking involves the process of storing stem cells – agent responsible for replenishing the blood and immune system – collected from the umbilical cord immediately after birth. The stem cells have the ability to develop into new and healthy red blood cells, white blood cells, and platelets.
It is done after the baby is born and the umbilical cord has been clamped and cut. Once it has been collected, the cord blood is transported to a cord blood processing and cryopreservation facility for specialized handling. Stem cells will be extracted from cord blood using the world’s first and only fully automated cord blood processing system, Sepax ®, followed by a step to gradually freeze down the stem cells before they are finally stored in a liquid nitrogen tank at -196°C permanently without losing its viability or biological activity. This operation is guaranteed safe and painless for both the mother and the baby.
Researchers say stem cells from cord blood may be used to treat diseases of the family members since the chance of locating a cord blood match within the family is 60 percent higher than a bone marrow match, includes fewer complications, and has improved medical outcomes. Stem cells have been proven to successfully treat diseases including cancers such as leukemia, lymphoma, neuroblastoma, blood disorders such as thalassaemia as well as immune deficiencies and metabolic disorders.
Cord blood banking is available at CordLife, the Philippines’ first world-class cord blood processing and storage facility which is located at the UP-AyalaLand TechnoHub Diliman, Q.C. Meanwhile, stem cell transplants are performed in The National Kidney and Transplant Institute, St. Luke’s Medical Center, Asian Hospital and Medical Center. These hospitals have the necessary facilities and expertise of medical practitioners to perform cord blood banking transplants
CordLife was established to provide a full suite of cord blood and tissue banking services, which include the collection, processing and cryopreservation storage of cord blood stem cells and umbilical cord tissue. Since its inception in 2001, CordLife has grown rapidly from a fledging start-up company to the largest network of cord blood banks in the Asia-Pacific region. Our in-depth knowledge of cord blood banking practices and standards has developed strong capabilities to attain certifications from quality standard organizations such as the International Organization for Standardization (ISO) and country regulators. The prestigious “Technology Pioneer” title awarded by the World Economic Forum ascertained our outstanding performance in the industry.
Today, the CordLife group of companies (CordLife Limited) is listed on the Australian Securities Exchange (ASX:CBB),which owns and operates cord blood processing and tissue storage facilities situated in Indonesia, India, and the Philippines.
CordLife aims to offer the highest possibility of successful adult stem cell therapy to give hope and save lives.
For more information on CordLife and cord blood banking, visit www.cordlife.com/ph or call 710-9195.
E-mail address: info@ph.cordlife.com
